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Background
Progesterone induced dermatitis is a rare autoimmune
response to endogenous progesterone that usually occurs
in fertile females, in the third decade. Skin lesions occur
periodically during the luteal phase of the menstrual
cycle due to increase of progesterone, the symptom
usually occurs 3-10 days prior to the onset of menstrual
flow and resolve 2 days into menses. It may present a
variety of cutaneous and mucosal manifestations, from a
mild urticarial to an anaphylaxis.
Methods
We report a case of autoimmune progesterone dermati-
tis (AIPD) in a woman who had placed an intrauterine
device (IUD) three months before the beginning of the
symptoms.
A 37-year-old woman was first seen presenting an ede-
matous erythematous scaly pruritic eruption a few days
after levofloxacin treatment for sinusitis. Skin biopsy had
showed perivascular inflammatory infiltrates and frequent
eosinophils and rare extravasated erythrocytes suggesting
skin drug reaction. Although she had used antihistamines
and high dosing corticosteroid for six months, had got any
better. Patient reinforced skin lesions worsening on pre-
menstrual period. History of IUD placement 3 months
before.
Results
After IUD removal without improvement, it was per-
formed a progesterone intradermal skin test (IDST) with
positive result. Now the patient is being treated with
tamoxifen successfully.
Conclusions
In AIPD, mechanisms by which endogenous progester-
one becomes antigenic is unknown. It is proposed that
previous exposure to exogenous progesterone, especially
oral contraceptives or IUD, sensitize presenting cells and
T helper 2 lymphocytes generate specific IgE antibodies,
which cause type 1 hypersentivity. Diagnosis criteria are:
(1) skin lesions related to menstrual cycle, (2) IDST posi-
tive and, (3) symptomatic improvement after inhibiting
progesterone secretion by suppression ovulation. AIPD
first line treatment is combined oral contraceptive, but it
is also described success with GnRH agonists, tamoxifen,
danazol or bilateral oophorectomy. The case report had
demonstrated a woman with typical symptoms, diagnosis
criteria and positive response to treatment.
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